pioglitazone has been researched along with Lichen Ruber Planus in 7 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Excerpt | Relevance | Reference |
---|---|---|
"Pioglitazone has been reported as a possible therapeutic option." | 3.11 | Efficacy and safety of oral pioglitazone in the management of lichen planopilaris in comparison with clobetasol: A randomized clinical trial. ( Azar, PM; Balighi, K; Daneshpazhooh, M; Dasdar, S; Ghiasi, M; Kianfar, N; Lajevardi, V; Peymanfar, AA, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Lajevardi, V | 1 |
Ghiasi, M | 1 |
Balighi, K | 1 |
Daneshpazhooh, M | 1 |
Azar, PM | 1 |
Kianfar, N | 1 |
Dasdar, S | 1 |
Peymanfar, AA | 1 |
Peterson, EL | 1 |
Gutierrez, D | 1 |
Brinster, NK | 1 |
Lo Sicco, KI | 1 |
Shapiro, J | 1 |
Preda-Naumescu, A | 1 |
Bevans, SL | 1 |
Mayo, TT | 1 |
Imanishi, H | 1 |
Ansell, DM | 1 |
Chéret, J | 1 |
Harries, M | 1 |
Bertolini, M | 1 |
Sepp, N | 1 |
Bíró, T | 1 |
Poblet, E | 1 |
Jimenez, F | 1 |
Hardman, J | 1 |
Panicker, SP | 1 |
Ward, CM | 1 |
Paus, R | 1 |
Spring, P | 1 |
Spanou, Z | 1 |
de Viragh, PA | 1 |
Mesinkovska, NA | 1 |
Tellez, A | 1 |
Dawes, D | 1 |
Piliang, M | 1 |
Bergfeld, W | 1 |
Mirmirani, P | 1 |
Karnik, P | 1 |
1 review available for pioglitazone and Lichen Ruber Planus
Article | Year |
---|---|
Pediatric Lichen Planopilaris Treated With Pioglitazone: A Case Study and Literature Review.
Topics: Alopecia; Child; Humans; Lichen Planus; Pioglitazone; Treatment Outcome | 2021 |
1 trial available for pioglitazone and Lichen Ruber Planus
Article | Year |
---|---|
Efficacy and safety of oral pioglitazone in the management of lichen planopilaris in comparison with clobetasol: A randomized clinical trial.
Topics: Adult; Alopecia; Clobetasol; Female; Humans; Lichen Planus; Male; Pioglitazone; Treatment Outcome | 2022 |
5 other studies available for pioglitazone and Lichen Ruber Planus
Article | Year |
---|---|
Response of Lichen Planopilaris to Pioglitazone Hydrochloride
Topics: Adult; Aged; Female; Humans; Immunologic Factors; Lichen Planus; Male; Middle Aged; Pioglitazone; PP | 2019 |
Epithelial-to-Mesenchymal Stem Cell Transition in a Human Organ: Lessons from Lichen Planopilaris.
Topics: Adult; Aged; Cells, Cultured; Epithelial-Mesenchymal Transition; Female; Humans; Keratin-15; Lichen | 2018 |
Lichen planopilaris treated by the peroxisome proliferator activated receptor-γ agonist pioglitazone: lack of lasting improvement or cure in the majority of patients.
Topics: Adult; Aged; Female; Humans; Lichen Planus; Male; Middle Aged; Pioglitazone; PPAR gamma; Prospective | 2013 |
The use of oral pioglitazone in the treatment of lichen planopilaris.
Topics: Administration, Oral; Alopecia; Disease Progression; Edema; Female; Follow-Up Studies; Humans; Liche | 2015 |
Lichen planopilaris treated with a peroxisome proliferator-activated receptor gamma agonist.
Topics: Alopecia; Humans; Hypoglycemic Agents; Lichen Planus; Male; Middle Aged; Pioglitazone; PPAR gamma; S | 2009 |